[125I]Iodomethyllycaconitine binds to α7 nicotinic acetylcholine receptors in monkey brain

European Journal of Neuroscience

Volumn 23, Issue 10, 2006, Pages 2604-2610

  Kulak, Jennifer M ^a   Ivy Carroll, F ^b   Schneider, Jay S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

M. cynomologous; Macaque; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA BUNGAROTOXIN; ALPHA CONOTOXIN MII; IODINE 125; IODOMETHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; ALPHA-BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR; DIAGNOSTIC AGENT; FUSED HETEROCYCLIC RINGS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CAUDATE NUCLEUS; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; EXPERIMENTATION; IN VIVO STUDY; INHIBITION KINETICS; MACACA; MONKEY; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RADIOASSAY; RECEPTOR BINDING; STATISTICAL ANALYSIS; THALAMUS; ANIMAL; AUTORADIOGRAPHY; BINDING COMPETITION; METABOLISM; PARKINSONISM;

ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; MACACA FASCICULARIS; PARKINSONIAN DISORDERS; RECEPTORS, NICOTINIC;

EID: 33744465256     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04804.x     Document Type: Article

References (36)

1. Changeux, J.P., Bertrand, D., Corringer, P.J., Dehaene, S. Edelstein, S., Lena, C., Le Novere, N., Marubio, L., Picciotto, M. Zoli, M. 1998 Brain nicotinic receptors: structure and regulation, role in learning and reinforcement, Brain Res. Brain Res. Rev., 26, 198 216.
2. Cimino, M., Marini, P., Fornasari, D., Cattabeni, F. Clementi, F. 1992 Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of α3 subunit mRNA, α-bungarotoxin and nicotine binding sites. Neuroscience, 51, 77 88.
3. Clarke, P.B.S., Schwartz, R.D., Paul, S.M., Pert, C.B. Pert, A. 1985 Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-a-bungarotoxin. J. Neurosci., 5, 1307 1315.
4. Court, J.A., Martin-Ruiz, C., Graham, A. Perry, E. 2000 Nicotinic receptors in human brain: topography and pathology. J. Chem. Neuroanat., 20, 281 298.
5. Court, J., Martin-Ruiz, C., Piggott, M., Spurden, D., Griffiths, M. Perry, E. 2001 Nicotinic receptor abnormalities in Alzheimer's disease. Biol. Psychiatry, 49, 175 184.
6. Davies, A.R., Hardick, D.J., Blagbrough, I.S., Potter, B.V., Wolstenholme, A.J. Wonnacott, S. 1999 Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology, 38, 679 690.
7. Ding, Y.S., Gatley, S.J., Fowler, J.S., Volkow, N.D., Aggarwal, D., Logan, J., Dewey, S.L., Liang, F., Carroll, F.I. Kuhar, M.J. 1996 Mapping nicotinic acetylcholine receptors with PET. Synapse, 24, 403 407.
8. Dowell, C., Olivera, B.M., Garrett, J.E., Staheli, S.T., Watkins, M., Kuryatov, A., Yoshikami, D., Lindstrom, J.M. McIntosh, J.M. 2003 α-Conotoxin PIA is selective for α6-subunit containing nicotinic acetylcholine receptors. J. Neurosci., 23, 8445 8452.
9. Dwoskin, L.P. Crooks, P.A. 2001 Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J. Pharm. Exp. Ther., 298, 395 402.
10. Fujita, M., Ichise, M., Zoghbi, S.S., Liow, J.S., Ghose, S., Vines, D.C., Sangare, J., Lu, J.Q., Cropley, V.L., Iida, H., Kim, K.M., Cohen, R.M., Bara-Jimenez, W., Ravina, B. Innis, R.B. 2006 Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease. Ann. Neurol., 59, 174 177.
11. Gotti, C., Fornasari, D. Clementi, F. 1997 Human neuronal nicotinic receptors. Prog. Neurobiol., 53, 199 237.
12. Han, Z.-Y., Zoli, M., Cardona, A., Bourgeois, J.-P., Changeux, J.-P. Le Novere, N. 2003 Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]α-bungarotoxin binding sites in the brain of Macaca mulatta. J. Comp. Neurol., 461, 49 60.
13. Heiss, W.D. Herholz, K. 2006 Brain receptor imaging. J. Nucl. Med., 47, 302 312.
14. Kaiser, S. Wonnacott, S. 2000 α-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [3H]dopamine release in rat striatal slices via glutamate release. Mol. Pharmacol., 58, 312 318.
15. Kulak, J.M., Fan, H. Schneider, J.S. 2004 Decreases in β4* and β2* nicotinic receptor expression in MPTP-treated monkeys with cognitive and motor deficits. Soc. Neurosci. Abstr., 30, 48.23.
16. Kulak, J.M., McIntosh, J.M. Quik, M. 2002a Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in α-conotoxin MII sites. Mol. Pharmacol., 61, 230 238.
17. Kulak, J.M., Musachio, J.L., McIntosh, J.M. Quik, M. 2002b Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage. J. Pharmacol. Exp. Ther., 303, 633 639.
18. Kulak, J.M. Schneider, J.S. 2004 Differences in α7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys. Brain Res., 999, 193 202.
19. Kulak, J.M., Sum, J., Musachio, J.L., McIntosh, J.M. Quik, M. 2002c 5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes. J. Neurochem., 81, 403 406.
20. Lloyd, G.K. Williams, M. 2000 Neuronal nicotinic acetylcholine receptors as novel drug targets. J. Pharmacol. Exp. Ther., 292, 461 467.
21. Lukas, R.J., Changeux, J.P., Le Novere, N., Albuquerque, E.X., Balfour, D.J., Berg, D.K., Bertrand, D., Chiappinelli, V.A., Clarke, P.B., Collins, A.C., Dani, J.A., Grady, S.R., Kellar, K.J., Lindstrom, J.M., Marks, M.J., Quik, M., Taylor, P.W. Wonnacott, S. 1999 International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev., 51, 397 401.
22. Marks, M.J., Stitzel, J.A., Romm, E., Wehner, J.M. Collins, A.C. 1986 Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and α-bungarotoxin. Mol. Pharmacol., 30, 427 436.
23. Mogg, A.J., Whiteaker, P., McIntosh, J.M., Marks, M., Collins, A.C. Wonnacott, S. 2002 Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. J. Pharmacol. Exp. Ther., 302, 197 204.
24. Navarro, H.A., Xu, H., Zhong, D., Abraham, P. Carroll, F.I. 2002 In vitro and in vivo characterization of [125I]iodomethyllycaconitine in the rat. Synapse, 44, 117 123.
25. Navarro, H.A., Zhong, D., Abraham, P., Xu, H. Carroll, F.I. 2000 Synthesis and pharmacological characterization of [(125)I]iodomethyllycaconitine ([(125)I]iodo-MLA). A new ligand for the alpha (7) nicotinic acetylcholine receptor. J. Med. Chem., 43, 142 145.
26. Perry, E.K., Perry, R.H., Smith, C.J., Purohit, D., Bonham, J., Dick, D.J., Candy, J.M., Edwardson, J.A. Fairbairn, A. 1986 Cholinergic receptors in cognitive disorders. Can. J. Neurol. Sci., 13, 521 527.
27. Quik, M., Polonskaya, Y., Kulak, J.M. McIntosh, J.M. 2001 Vulnerability of 125I-α-conotoxin MII binding sites to nigrostriatal damage in monkey. J. Neurosci., 21, 5494 5500.
28. Quik, M., Polonskaya, Y., McIntosh, J.M. Kulak, J.M. 2002 Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage. Neuroscience, 112, 619 630.
29. Schneider, J.S., Decamp, E. Wade, T. 1999a Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology. J. Neurosci., 19, 6643 6649.
30. Schneider, J.S., Tinker, J.P., Van Velson, M., Menzaghi, F. Lloyd, G.K. 1999b Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys. J. Pharmacol. Exp. Ther., 290, 731 739.
31. Schneider, J.S., Van Velson, M., Menzaghi, F. Lloyd, G.K. 1998 Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment. Ann. Neurol., 43, 311 317.
32. Schneider, J.S., Yuwiler, A. Markham, C.H. 1987 Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res., 411, 144 150.
33. Sihver, W., Nordberg, A., Langstrom, B., Mukhin, A.G., Koren, A.O., Kimes, A.S. London, E.D. 2000 Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav. Brain Res., 113, 143 157.
34. Volkow, N.D., Ding, Y.-S., Fowler, J.S. Gatley, S.J. 2001 Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia. Biol. Psych., 49, 211 221.
35. Ward, J.M., Cockcroft, V.B., Lunt, G.G., Smillie, F.S. Wonnacott, S. 1990 Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett., 270, 45 48.
36. Whiteaker, P., Davies, A.R., Marks, M.J., Blagbrough, I.S., Potter, B.V., Wolstenholme, A.J., Collins, A.C. Wonnacott, S. 1999 An autoradiographic study of the distribution of binding sites for the novel α7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur. J. Neurosci., 11, 2689 2696.